I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
White Dot Syndromes: Understanding Inflammatory Conditions of the Retina
Understanding White Dot Syndromes
White dot syndromes share a distinctive appearance on examination, but they are not all the same condition. Understanding what unites them and what sets each one apart helps clarify why each type is managed differently.
White dot syndromes are collectively referred to as inflammatory chorioretinopathies, a term meaning inflammation that affects the retina and choroid together. What they share is a pattern of discrete white or yellow-white spots visible in the deep retinal layers during examination. These spots represent areas where inflammation has disrupted the outer retina, the retinal pigment epithelium (commonly abbreviated as RPE), and the choriocapillaris (the fine capillary network within the choroid). Despite looking similar at first glance, each condition within this group has its own patient profile, clinical features, and long-term outlook.
The exact cause of most white dot syndromes is not fully understood. Current evidence points to autoimmune or inflammatory mechanisms, in which the immune system mistakenly targets structures in the outer retina and choroid. Several of these conditions are preceded by a viral illness or upper respiratory infection, suggesting that an immune trigger may initiate the inflammatory process. In self-limiting forms, the inflammation subsides on its own and the retinal structures recover. In chronic forms, the inflammation persists or recurs, causing progressive damage over time.
One of the most clinically important distinctions within this group is whether a white dot syndrome resolves on its own or requires long-term treatment. Self-limiting forms, such as multiple evanescent white dot syndrome and acute posterior multifocal placoid pigment epitheliopathy, typically resolve over weeks to months and carry a favorable visual prognosis. Chronic forms, including birdshot chorioretinopathy, serpiginous choroiditis, and multifocal choroiditis with panuveitis, require ongoing immunosuppressive therapy to prevent cumulative damage to vision over time.
Self-Limiting White Dot Syndromes
Some white dot syndromes follow a natural, self-resolving course. While they can cause significant symptoms during the acute phase, most patients with these conditions recover well with monitoring and supportive care.
Multiple evanescent white dot syndrome (MEWDS) is one of the most recognizable self-limiting white dot syndromes. It most commonly affects young women with myopia (nearsightedness) and often follows a viral illness. Patients typically develop sudden blurred vision, photopsias (flashing or flickering lights not caused by any external source), and visual field defects in one eye. On examination, the characteristic finding is multiple small white dots in the deep retina, along with a granular or stippled appearance at the fovea (the small central area of the macula responsible for sharp, detailed vision). MEWDS typically resolves on its own over several weeks to months, and most patients recover their pre-illness level of vision. Treatment beyond watchful observation is generally not necessary.
Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is another condition that often follows a viral illness, but unlike MEWDS, it usually affects both eyes. Young, otherwise healthy adults are most commonly affected. Patients experience rapid-onset blurred central vision, and examination reveals multiple flat, cream-colored or gray-white lesions at the level of the RPE. These lesions fade over the course of weeks, and most patients regain good visual acuity, though some degree of pigmentary change in the RPE may remain. In rare cases, APMPPE has been associated with inflammation of the blood vessels of the brain (cerebral vasculitis). Any accompanying neurological symptoms, such as severe headache, confusion, or sudden weakness, should be reported to a physician right away.
Acute zonal occult outer retinopathy (AZOOR) is characterized by the sudden onset of photopsias and visual field loss, often with very little to find on initial examination. The word 'occult' reflects that early findings can be subtle and easy to miss without advanced imaging. The outer retina is affected in a zone-like pattern, and changes typically become clearer on imaging as the condition evolves. AZOOR may involve one or both eyes and can sometimes appear alongside other white dot syndromes. Visual field defects may partially improve over time, but in some cases they remain stable. Regular monitoring with visual field testing and OCT imaging is important to track how the condition progresses.
Chronic White Dot Syndromes
Chronic white dot syndromes do not resolve on their own. They require active, ongoing management to control inflammation and prevent progressive loss of vision. Early diagnosis and consistent treatment are critical for the best long-term outcome.
Birdshot chorioretinopathy is a chronic bilateral (affecting both eyes) inflammatory condition named for the scattered, cream-colored lesions distributed across the fundus (the interior back surface of the eye), resembling the pattern of birdshot pellets. The condition most often affects adults in their forties through sixties and is strongly associated with the HLA-A29 genetic marker, which is found in approximately 90 percent of affected patients. Symptoms may develop gradually and include floaters, decreased night vision, reduced color perception, and progressive blurring of central vision. Birdshot chorioretinopathy requires long-term immunosuppressive therapy to prevent cumulative visual decline. Left uncontrolled, the chronic inflammation can permanently damage the photoreceptors and surrounding retinal tissue.
Multifocal choroiditis with panuveitis (MCP) is a chronic inflammatory condition that produces multiple punched-out chorioretinal lesions along with vitreous inflammation (cloudiness within the gel-filled interior of the eye). It predominantly affects young to middle-aged women and may involve one or both eyes. MCP can follow a relapsing and remitting course, meaning it may flare, quiet down, and then flare again, with new lesions potentially appearing during each episode. A significant concern is the development of choroidal neovascularization (CNV), meaning the growth of abnormal new blood vessels beneath the retina, which can cause rapid and significant central vision loss. Treatment typically involves corticosteroids and immunosuppressive medications, with anti-VEGF injections added when CNV is present.
Punctate inner choroiditis (PIC) is characterized by small, well-defined white or yellow lesions in the inner choroid, typically appearing in young myopic women. A key feature that distinguishes PIC from MCP is the absence of significant vitreous inflammation. The lesions tend to cluster near the macula, placing central vision at particular risk. Like MCP, a major complication of PIC is the development of choroidal neovascularization. Management focuses on monitoring for this complication and treating it promptly with anti-VEGF injections when it occurs. Immunosuppressive therapy may also be used for recurrent or persistent inflammation.
Serpiginous choroiditis is a chronic, progressive condition in which areas of chorioretinal atrophy (tissue loss affecting both the choroid and retina) spread outward from the optic disc or macula in a winding, snake-like pattern. Each episode of active inflammation adds a new zone of damage adjacent to previously affected areas. When this spreading damage reaches the fovea, central vision can be significantly impaired. Treatment with immunosuppressive therapy aims to prevent further episodes of active inflammation and limit the extent of long-term chorioretinal damage. Ruling out tuberculosis as an underlying cause is an essential early step, since tuberculosis-related chorioretinal inflammation can look very similar to serpiginous choroiditis but requires antimicrobial treatment rather than immunosuppression alone.
Recognizing the Symptoms
The symptoms of white dot syndromes overlap with those of other retinal conditions, which is one reason why evaluation by a retina specialist is important. Knowing what to watch for can help you seek care at the right time.
Blurred vision is the most frequent complaint across all white dot syndromes. Photopsias (flashing or flickering lights not caused by any outside source) are especially prominent in MEWDS and AZOOR. Floaters, perceived as small spots, strands, or shadows that drift through the field of vision, occur when there is associated vitreous inflammation. Visual field defects, experienced as blind spots, shadows, or missing areas in the peripheral or central field of view, may also be present. Patients with birdshot chorioretinopathy in particular often report reduced night vision and a noticeable change in color perception.
The speed at which symptoms appear is itself a diagnostic clue. MEWDS and APMPPE typically present acutely, with symptoms developing over hours to days, often shortly after a viral illness. Birdshot chorioretinopathy tends to develop more gradually, with patients noticing subtle changes over weeks to months before seeking evaluation. Chronic conditions can have periods of relative stability interrupted by episodes of worsening symptoms during flares of inflammation. Whether your symptoms came on suddenly or have built up gradually, reporting them promptly allows your retina specialist to evaluate your condition in a timely way.
Sudden loss of vision, the appearance of new blind spots, a significant increase in floaters, or new flashing lights should be evaluated promptly rather than monitored at home. This applies particularly to young adults who have recently had a viral illness or respiratory infection. While some white dot syndromes are self-limiting, others can progress quickly and benefit from early diagnosis and treatment. When in doubt, it is always better to be evaluated and reassured than to delay and risk missing a complication that needed early attention.
How We Diagnose White Dot Syndromes
Diagnosing white dot syndromes requires a combination of clinical expertise and advanced retinal imaging. Our retina specialists use a structured, multimodal approach to reach an accurate diagnosis and build a clear plan for your care.
The starting point is a thorough dilated fundus examination, in which widening eye drops are used to allow a detailed view of the retina, macula, and choroid. The size, shape, location, and depth of white lesions provide critical diagnostic clues. The presence or absence of vitreous inflammation and any changes at the optic nerve or macula also inform the initial assessment. Slit-lamp examination evaluates for inflammation in the front chamber of the eye as well.
Advanced imaging plays a central role in both diagnosing and monitoring white dot syndromes. We use complementary imaging technologies to build a complete picture of what is happening across the layers of the retina and choroid.
- OCT (optical coherence tomography) provides cross-sectional images of the retinal layers, revealing structural disruption in the outer retina and RPE that may not be visible on examination alone.
- Fluorescein angiography uses an injected dye to highlight blood vessel patterns, revealing characteristic areas of abnormal leakage or blockage that differ by condition.
- Indocyanine green (ICG) angiography provides detailed visualization of choroidal blood flow and often reveals more extensive disease than is apparent on clinical examination or fluorescein angiography alone.
- Fundus autofluorescence uses the natural fluorescent properties of the RPE to highlight areas of dysfunction and help track the extent of involvement over time.
Formal visual field testing documents areas of reduced sensitivity or blind spots that may not be immediately apparent to the patient. This is especially important in AZOOR, where visual field loss is often the most prominent finding. Serial visual field testing allows us to track whether defects are improving, stable, or progressing over time. Electroretinography (ERG), which measures the electrical response of the retina's photoreceptors and other cells, may be ordered in selected cases, particularly when visual symptoms seem out of proportion to the visible findings on examination.
Laboratory tests help narrow the diagnosis and rule out conditions that can appear similar to white dot syndromes. HLA-A29 genetic testing supports a diagnosis of birdshot chorioretinopathy when the clinical picture is consistent. Testing for tuberculosis, syphilis, and other infections may be performed to exclude infectious causes of similar-appearing chorioretinal lesions. The specific tests ordered depend on the clinical presentation and which diagnoses are being actively considered.
Treatment Options
Treatment varies considerably depending on which white dot syndrome is present. Self-limiting conditions call for a very different approach than chronic conditions requiring long-term therapy. Our retina specialists tailor treatment to each patient's specific diagnosis, disease activity, and overall health.
For self-limiting white dot syndromes such as MEWDS and typical APMPPE, careful observation with scheduled follow-up is the primary approach. These conditions resolve without treatment, and supportive care is generally all that is needed. Follow-up visits with clinical examination and imaging confirm that the condition is progressing along its expected natural course. Patients are counseled on what to expect during recovery and which symptoms should prompt them to return for an earlier evaluation.
Corticosteroids (anti-inflammatory steroid medications) may be used when white dot syndromes cause significant inflammation or threaten vision. Depending on the location and severity of inflammation, they can be delivered as eye drops, periocular injections (around the outside of the eye), intravitreal injections (directly into the eye), or oral medications. Corticosteroids are effective for controlling acute inflammation but are not suitable for prolonged use because of potential side effects, including elevated eye pressure and earlier cataract formation. In chronic conditions, they often serve as a short-term bridge while longer-acting immunosuppressive medications are established.
Chronic white dot syndromes such as birdshot chorioretinopathy, serpiginous choroiditis, and recurrent multifocal choroiditis with panuveitis typically require long-term immunosuppressive therapy to control ongoing inflammation and prevent progressive visual loss. Medications used in this setting include antimetabolites, calcineurin inhibitors, and biologic agents. The choice of medication depends on the specific condition, its severity, and the patient's overall health and other medical considerations. These medications require regular blood test monitoring to watch for side effects, and our retina specialists coordinate with other physicians as needed to manage therapy safely.
Choroidal neovascularization (CNV), the growth of abnormal blood vessels beneath the retina, is a recognized complication of several white dot syndromes, particularly multifocal choroiditis with panuveitis and punctate inner choroiditis. When CNV is identified, anti-VEGF injections are used to block abnormal vessel growth and reduce the leakage that can damage the macula. Controlling the underlying inflammation with immunosuppressive therapy also helps reduce the risk of new CNV developing. Other complications, such as cystoid macular edema (fluid accumulation within the macula), may be treated with periocular or intravitreal steroid injections.
Prognosis and Long-Term Care
Understanding what to expect over time depends largely on which condition you have. With an accurate diagnosis, appropriate treatment, and consistent monitoring, many patients are able to maintain good functional vision over the long term.
The visual prognosis differs significantly across white dot syndromes. MEWDS carries an excellent prognosis, with most patients recovering their baseline visual acuity within weeks. APMPPE also generally has a favorable outlook, though some patients may be left with lasting RPE changes that subtly affect vision quality. Birdshot chorioretinopathy, serpiginous choroiditis, and multifocal choroiditis with panuveitis carry a more guarded long-term prognosis, because chronic or recurrent inflammation can gradually erode visual function even with treatment. Early diagnosis and consistent adherence to a treatment plan offer the best opportunity to preserve vision over the years.
The frequency of follow-up depends on the type of white dot syndrome and how it is behaving clinically. Self-limiting conditions may require only a few visits to confirm resolution. Chronic conditions require regular, long-term monitoring with imaging, visual field testing, and ongoing assessment of inflammatory activity. Your retina specialist will develop an individualized monitoring schedule based on your specific condition and how it responds to treatment. Keeping all scheduled appointments is an important part of protecting your vision, even during periods when your symptoms feel stable.
If you have a chronic white dot syndrome that requires immunosuppressive therapy, staying consistent with your medications and follow-up appointments is the most important step you can take to preserve your long-term vision. Taking medications as directed, attending all monitoring visits, and notifying your care team promptly when your vision changes all help ensure your treatment plan stays effective. It is also helpful to understand that periodic adjustments to the treatment plan are a normal and expected part of managing a chronic condition, not a sign that something is going wrong.
Frequently Asked Questions
The following questions address common concerns we hear from patients who are newly learning about a white dot syndrome diagnosis or who have been referred for further evaluation.
Yes, follow-up remains important even when the condition is expected to resolve on its own. While MEWDS and typical APMPPE generally improve without treatment, monitoring is needed to confirm that recovery is progressing as expected and that no complications are developing along the way. In a small number of cases, conditions that initially appear self-limiting can take a more prolonged or atypical course, and scheduled follow-up allows your retina specialist to identify any deviation early and adjust the approach if needed.
This depends on the specific condition. MEWDS is generally a single episode in most patients, though recurrences have been documented. Chronic conditions such as multifocal choroiditis with panuveitis, punctate inner choroiditis, and birdshot chorioretinopathy are defined in part by their tendency to flare, which is one reason long-term treatment is maintained even during quiet periods. If you notice a return of familiar symptoms after a period of improvement, contact your retina specialist promptly rather than waiting to see if they settle on their own. Early evaluation during a flare offers the best opportunity to limit additional damage.
Choroidal neovascularization refers to the growth of abnormal, fragile blood vessels beneath the retina. These vessels can leak fluid or bleed, distorting or reducing central vision fairly quickly if left untreated. Anti-VEGF injections are effective at suppressing this abnormal vessel activity, and early detection through regular monitoring gives us the best chance of treating the problem before significant central vision loss occurs. This is one of the key reasons why keeping imaging appointments matters even when your vision feels stable between visits.
Tuberculosis (TB) can cause chorioretinal inflammation that closely resembles serpiginous choroiditis in particular. The distinction matters greatly because TB-related eye disease requires antimicrobial treatment, either instead of or alongside immunosuppression. Giving immunosuppressive therapy alone to a patient with unrecognized TB could allow an underlying infection to worsen while appearing to suppress the visible eye inflammation. Ruling out TB early ensures that your treatment targets the correct underlying cause from the start.
Sudden, significant changes in vision should always be evaluated the same day, without waiting for your next scheduled appointment. This includes sudden blurring, a new large blind spot or shadow in your visual field, a dramatic increase in floaters, or a new curtain or veil across part of your vision. If you have an existing white dot syndrome and notice a change from your usual baseline, reach out to your retina specialist right away rather than monitoring it at home. Prompt evaluation can make a meaningful difference in outcome when a complication is identified and treated early.
Most white dot syndromes do not follow a clearly inherited pattern. However, certain conditions have notable genetic associations. Birdshot chorioretinopathy is the clearest example, with approximately 90 percent of patients carrying the HLA-A29 genetic marker. Carrying this marker does not guarantee the condition will ever develop, and most people with the marker never experience birdshot chorioretinopathy. The relationship between genetic predisposition and the immune triggers that initiate inflammation remains an active area of investigation in retinal medicine.
Care for White Dot Syndromes at New England Retina Associates
If you have been referred for evaluation of a white dot syndrome or are experiencing unexplained visual symptoms, New England Retina Associates welcomes both referred and self-referred patients across Connecticut. Our fellowship-trained vitreoretinal surgeons bring specialized expertise in inflammatory retinal conditions, supported by advanced diagnostic imaging and a full range of treatment options. We are committed to providing individualized, thorough care so that you can protect your vision and approach your diagnosis with confidence.
30 Years of Care & Commitment
